American BriVision (Holding) Corporation Stock OTC Markets
Equities
ABVC
US0247332069
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 0.97 | Sales 2023 | 0.15 | Capitalization | 8.95M |
---|---|---|---|---|---|
Net income 2022 | -16M | Net income 2023 | -10M | EV / Sales 2022 | 24,208,439 x |
Net Debt 2022 | 3.25M | Net Debt 2023 | 2.31M | EV / Sales 2023 | 73,880,417 x |
P/E ratio 2022 |
-1.2
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.57% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23-06-22 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 21-02-28 |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 22-07-09 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |